biomarkers

J&J's quest to detect lung cancer before it emerges
J&J's quest to detect lung cancer before it emerges
Fierce Biotech
JNJ
smoking
lung cancer
MRNA
biomarkers
Flag link:
Baxter, Biomérieux ink acute kidney injury biomarker dev deal
Baxter, Biomérieux ink acute kidney injury biomarker dev deal
Mass Device
Baxter
Biomerieux
acute kidney injury
biomarkers
Flag link:
FDA qualifies first biomarker test for brain injury
FDA qualifies first biomarker test for brain injury
BioCentury
FDA
traumatic brain injury
diagnostics
biomarkers
OsiriX
Flag link:
New Test Measures Pain Levels Using Biomarkers in the Blood
New Test Measures Pain Levels Using Biomarkers in the Blood
BioSpace
biomarkers
painkillers
diagnostics
opioid crisis
Flag link:
ALS researchers at Harvard uncover new biomarker and drug target
ALS researchers at Harvard uncover new biomarker and drug target
Fierce Biotech
ALS
Lou Gehrig's disease
Harvard
biomarkers
Flag link:
Phoenix, Roche partner to develop TNBC biomarker
Phoenix, Roche partner to develop TNBC biomarker
BioCentury
Roche
Phoenix Molecular Designs
diagnostics
molecular diagnostics
triple negative breast cancer
biomarkers
Flag link:
Data Scientist Explains How AI's Seductive Power Can Mislead Biomarker Researchers
Data Scientist Explains How AI's Seductive Power Can Mislead Biomarker Researchers
Forbes
artificial intelligence
biomarkers
Flag link:
Merck taps Roche for Keytruda companion diagnostic
Merck taps Roche for Keytruda companion diagnostic
Medtech Dive
Merck
Roche
solid tumors
oncology
biomarkers
companion diagnostics
diagnostics
Flag link:
Cellanyx Publishes Clinical Proof-of-Concept Study of First-in-Class Biomarker Test to Determine Prostate Cancer Risk
Cellanyx Publishes Clinical Proof-of-Concept Study of First-in-Class Biomarker Test to Determine Prostate Cancer Risk
CP Wire
Cellanyx
prostate cancer
biomarkers
diagnostics
Flag link:
FDA grants first qualification of a clinical safety biomarker
FDA grants first qualification of a clinical safety biomarker
BioCentury
FDA
biomarkers
acute kidney injury
Flag link:
[release] Firalis and Celemics announce an agreement for the commercialization of a unique proprietary long non- coding RNA (lncRNA) panel, FiMICS®
[release] Firalis and Celemics announce an agreement for the commercialization of a unique proprietary long non- coding RNA (lncRNA) panel, FiMICS®
CP Wire
Firalis
Celemics
genomics
biomarkers
IncRNAs
FiMICS
Flag link:
[release] Firalis and Celemics announce an agreement for the commercialization of a unique proprietary long non- coding RNA (lncRNA) panel, FiMICS®
Firalis
Celemics
genomics
biomarkers
IncRNAs
FiMICS
Flag link:
Diagnosing Depression By Blood Biomarkers: A Viable Approach?
Diagnosing Depression By Blood Biomarkers: A Viable Approach?
Forbes
depression
biomarkers
diagnostics
Nano Vision
Flag link:
Genentech signs $534M deal with Microbiotica to search gut bacteria for IBD targets, new drugs
Genentech signs $534M deal with Microbiotica to search gut bacteria for IBD targets, new drugs
Fierce Biotech
Genentech
Microbiotica
microbiome
IBD
biomarkers
Flag link:
ASCO: Bristol-Myers racks up Opdivo combo data to sell its new biomarker, but will doctors buy it?
ASCO: Bristol-Myers racks up Opdivo combo data to sell its new biomarker, but will doctors buy it?
Fierce Pharma
Bristol-Myers Squibb
biomarkers
ASCO 2018
Opdivo
Flag link:
Preliminary Study Finds Potential Biomarker of Subconcussive Head Trauma
Preliminary Study Finds Potential Biomarker of Subconcussive Head Trauma
CP Wire
biomarkers
concussions
head trauma
Flag link:
Researchers at UC San Diego Developing Blood Test for Early Pancreatic Cancer Detection
Researchers at UC San Diego Developing Blood Test for Early Pancreatic Cancer Detection
CP Wire
pancreatic cancer
diagnostics
biomarkers
Flag link:
CytoReason Cements Proof-of-Concept with Machine-Learning-Facilitated Biomarker Breakthrough in Inflammatory Bowel Disease
CytoReason Cements Proof-of-Concept with Machine-Learning-Facilitated Biomarker Breakthrough in Inflammatory Bowel Disease
CP Wire
CytoReason
IBD
inflammatory bowel disease
biomarkers
Flag link:
After yet another PhIII Alzheimer’s failure, experts try to map a path out of the wrecking field
After yet another PhIII Alzheimer’s failure, experts try to map a path out of the wrecking field
Endpoints
FDA
Alzheimer's disease
R&D
NIH
biomarkers
Flag link:
First patient dosed in unique biomarker guided Ph III study of enzastaurin + R-CHOP in high-risk diffuse large B-cell lymphoma (DLBCL)
First patient dosed in unique biomarker guided Ph III study of enzastaurin + R-CHOP in high-risk diffuse large B-cell lymphoma (DLBCL)
CP Wire
biomarkers
enzastaurin
Denovo Therapeutics
DLBCL
R-CHOP
Flag link:

Pages